Works matching DE "BARICITINIB"

Results: 360

Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. 1072, doi. 10.1111/jdv.20691

By:

Saceda‐Corralo, David;
Vañó‐Galván, Sergio

Publication type:

Article

Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. 1134, doi. 10.1111/jdv.20372

By:

Aceituno, D.;
Fawsitt, C. G.;
Power, G. M.;
Law, E.;
Vaghela, S.;
Thom, H.

Publication type:

Article

Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. e490, doi. 10.1111/jdv.20334

By:

Mostaghimi, Arash;
Augustin, Matthias;
Harada, Kazutoshi;
Senna, Maryanne;
Dutronc, Yves;
Yu, Guanglei;
Ball, Susan;
Murage, Mwangi;
Kolodsick, Jill;
Brogan, Yiying;
King, Brett

Publication type:

Article

Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 6, p. 1143, doi. 10.1111/jdv.20312

By:

Piraccini, B. M.;
Pampaloni, F.;
Cedirian, S.;
Quadrelli, F.;
Bruni, F.;
Rapparini, L.;
Caro, G.;
Acri, M. C.;
Ala, L.;
Rossi, A.;
Pellacani, G.;
Lacarrubba, F.;
Micali, G.;
Dall'Oglio, F.;
Vastarella, M.;
Cantelli, M.;
Nappa, P.;
Diluvio, L.;
Bianchi, L.;
Gnesotto, L.

Publication type:

Article

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 5, p. 599, doi. 10.1080/14740338.2024.2356020

By:

Zhu, Zhou;
Liu, Mingjuan;
Zhang, Hanlin;
Zheng, Heyi;
Li, Jun

Publication type:

Article

Refractory moderate-to-severe pediatric-onset alopecia areata with elevated serum IgE treated by JAK inhibitors.

Published in:

Indian Journal of Dermatology, Venereology & Leprology, 2025, v. 91, p. 1, doi. 10.25259/IJDVL_849_2023

By:

Wu, Yingying;
Deng, Lin;
Liu, Fang;
An, Binyi;
Liu, Haibo;
Sang, Hong;
Kong, Qingtao

Publication type:

Article

Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.

Published in:

Indian Journal of Pharmacology, 2022, v. 54, n. 3, p. 183, doi. 10.4103/ijp.ijp_1089_20

By:

Deepak, H;
Prince, Sabina;
Deshpande, Pratima

Publication type:

Article

Baricitinib as treatment for isolated severe nail lichen planus.

Published in:

2023

By:

Joãoa, Ana L.;
Caldeira, Margarida;
Cabete, Joana;
Cunha, Nélia;
Duarte, Bruno

Publication type:

Letter to the Editor

Successful treatment of hip involvement in SAPHO syndrome with baricitinib.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 3, p. 1, doi. 10.1093/rap/rkac084

By:

Wuriliga;
Wu, Xia;
Cao, Yihan;
Li, Chen

Publication type:

Article

Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.

Published in:

GeroScience, 2024, v. 46, n. 3, p. 2863, doi. 10.1007/s11357-024-01099-y

By:

Gáspár, Zsófia;
Szabó, Bálint Gergely;
Andrikovics, Hajnalka;
Ceglédi, Andrea;
RAJMON, Martin;
Ábrahám, Anita;
Várnai, Zsuzsanna;
Kiss-Dala, Noémi;
Szlávik, János;
Sinkó, János;
Vályi-Nagy, István;
Lakatos, Botond

Publication type:

Article

The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study.

Published in:

Journal of Cosmetic Dermatology, 2025, v. 24, n. 4, p. 1, doi. 10.1111/jocd.70185

By:

Gupta, Aditya K.;
Bamimore, Mary A.;
Mirmirani, Paradi;
Piguet, Vincent;
Talukder, Mesbah

Publication type:

Article

Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study.

Published in:

Journal of Cosmetic Dermatology, 2025, v. 24, n. 2, p. 1, doi. 10.1111/jocd.16666

By:

Stefanis, Athanasios J.;
Dolezal, Tomas;
Gkalpakiotis, Spyridon;
Arenberger, Petr

Publication type:

Article

Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study.

Published in:

Journal of Cosmetic Dermatology, 2024, v. 23, n. 4, p. 1417, doi. 10.1111/jocd.16123

By:

Bi, Lingbo;
Wang, Chaofan;
Du, Yimei;
Su, Tong;
Zhao, Min;
Lin, Xuewen;
Fan, Weixin;
Sun, Weiling

Publication type:

Article

Baricitinib for the treatment of rheumatoid arthritis.

Published in:

Rheumatology / Reumatologia, 2020, v. 58, n. 6, p. 407, doi. 10.5114/reum.2020.102006

By:

Urits, Ivan;
Israel, Jacob;
Hakobyan, Hayk;
Yusin, George;
Lassiter, Grace;
Fackler, Nathan;
Berger, Amnon A.;
Kassem, Hisham;
Kaye, Alan;
Viswanath, Omar

Publication type:

Article

Incidences of Herpes Zoster and Acne by Age in Japanese Patients With Atopic Dermatitis During Treatment With Baricitinib or Upadacitinib: A Single‐Centre Retrospective Study.

Published in:

Experimental Dermatology, 2025, v. 34, n. 4, p. 1, doi. 10.1111/exd.70100

By:

Watanabe, Ayu;
Kamata, Masahiro;
Okada, Yoshiki;
Tomura, Yayoi;
Tada, Yayoi

Publication type:

Article

Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone.

Published in:

Experimental Dermatology, 2024, v. 33, n. 12, p. 1, doi. 10.1111/exd.70024

By:

Calama, Elena;
Blanco, Ana I.;
Trincado, Juan L.;
Nueda, Arsenio;
Gil, Félix;
Aniorte, Gloria;
Godessart, Nuria;
Gavaldà, Amadeu

Publication type:

Article

Successful treatment of infantile refractory bullous pemphigoid with baricitinib.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 8, p. 642, doi. 10.1111/ajd.14345

By:

Zhou, Weinan;
Tan, Yidong;
Chen, Xuanyi;
Zhang, Wenqing;
Sun, Zhe;
Shen, Yihang;
Yao, Zhirong;
Cheng, Ruhong;
Gu, Yan

Publication type:

Article

JAK inhibitors in refractory dermatomyositis: A case series.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 7, p. 588, doi. 10.1111/ajd.14335

By:

Corbella‐Bagot, L.;
Bosch‐Amate, X.;
Gimeno‐Ribes, E.;
Gil‐Lianes, J.;
Giavedoni, P.;
Milisenda, J. C.;
Prieto‐González, S.;
Hurtado García, R.;
Mascaró, J. M.

Publication type:

Article

Baricitinib treatment of extragenital lichen sclerosus caused by COVID‐19 vaccine.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 4, p. 574, doi. 10.1111/ajd.14172

By:

Wang, Xin;
Shi, Yuling;
Liu, Yeqiang

Publication type:

Article

Nine cases of chronic hand and foot eczema treated with baricitinib.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 3, p. 408, doi. 10.1111/ajd.14074

By:

Lee, Sang‐Doo;
Ahn, Hye‐Jin;
Shin, Min Kyung

Publication type:

Article

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

Published in:

Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 276, doi. 10.1111/ajd.13811

By:

Moussa, Anthony;
Colla, Themis;
Morrison, Brendan;
Sinclair, Rodney

Publication type:

Article

Successful treatment of folliculitis decalvans with baricitinib: A case series.

Published in:

Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 279, doi. 10.1111/ajd.13786

By:

Moussa, Anthony;
Asfour, Leila;
Eisman, Samantha;
Bhoyrul, Bevin;
Sinclair, Rodney

Publication type:

Article

Repigmentation of vitiligo with oral baricitinib.

Published in:

Australasian Journal of Dermatology, 2020, v. 61, n. 4, p. 374, doi. 10.1111/ajd.13348

By:

Mumford, Blake P.;
Gibson, Andrew;
Chong, Alvin H.

Publication type:

Article

Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/ mTOR pathway via targeting JAK-STAT signaling of CD4<sup>+</sup> cells.

Published in:

Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1324892

By:

Shuang Chen;
Caihua Li;
Zeng Tu;
Tao Cai;
Xinying Zhang;
Lei Wang;
Ruoyuan Tian;
Jinglan Huang;
Yuxuan Gong;
Xiaotong Yang;
Zetong Wu;
Sirong He;
Wenyan He;
Dan Wang

Publication type:

Article

Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1293331

By:

Jin Zhang;
Xiongxiong Fan;
Xiaoyu Zhang;
Fengli Jiang;
Yiping Wu;
Beibei Yang;
Xinghuan Li;
Dong Liu

Publication type:

Article

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1265541

By:

Dastan, Farzaneh;
Jamaati, Hamidreza;
Barati, Saghar;
Varmazyar, Shahrzad;
Yousefian, Sahar;
Niknami, Elmira;
Tabarsi, Payam

Publication type:

Article

Baricitinib treatment for refractory skin changes in POEMS syndrome: a case report.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1191158

By:

Jingjing Xie;
Zhiling Li;
Yubao Jiang;
Dabin Tang;
Xia Qiu;
Ertao Jia;
Jianyong Zhang

Publication type:

Article

Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data.

Published in:

Current Medical Research & Opinion, 2024, v. 40, n. 11, p. 1993, doi. 10.1080/03007995.2024.2416979

By:

Edwards, Christoper J.;
Takeuchi, Tsutomu;
Finckh, Axel;
Kleyer, Arnd;
Haladyj, Ewa;
Gerwien, Jens Gammeltoft;
Treuer, Tamás;
Zaremba-Pechmann, Liliana;
Smolen, Josef S.

Publication type:

Article

Effectiveness and safety of baricitinib in patients with alopecia areata: a systematic review and Meta-analysis of randomized controlled trials.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 2, p. 249, doi. 10.1080/03007995.2022.2135838

By:

Mahmoud, Abdelrahman Mohamed

Publication type:

Article

The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis.

Published in:

PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0305621

By:

Qu, Bingjia;
Zhao, Feng;
Song, Ying;
Zhao, Junyi;
Yao, Yuxin;
Chen, Yulan;
Liao, Ruobing;
Fu, Lingyu

Publication type:

Article

A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.

Published in:

Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07087-5

By:

Bai, Wei;
Yang, Fan;
Xu, Huji;
Wei, Wei;
Li, Hongbin;
Zhang, Liyun;
Zhao, Yi;
Shi, Xiaofei;
Zhang, Yan;
Zeng, Xiaofeng;
Leng, Xiaomei

Publication type:

Article

Baricitinib reduces 30‐day mortality in older adults with moderate‐to‐severe COVID‐19 pneumonia.

Published in:

Journal of the American Geriatrics Society, 2021, v. 69, n. 10, p. 2752, doi. 10.1111/jgs.17357

By:

Abizanda, Pedro;
Calbo Mayo, Juan María;
Mas Romero, Marta;
Cortés Zamora, Elisa Belén;
Tabernero Sahuquillo, María Teresa;
Romero Rizos, Luis;
Sánchez‐Jurado, Pedro Manuel;
Sánchez‐Nievas, Ginés;
Campayo Escolano, Carlos;
Ochoa Serrano, Alba;
Sánchez‐Flor Alfaro, Victoria;
López Bru, Rita;
Gómez Ballesteros, Cristina;
Caldevilla Bernardo, David;
Callejas González, Francisco Javier;
Andrés‐Pretel, Fernando;
Lauschke, Volker Martin;
Stebbing, Justin

Publication type:

Article

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro.

Published in:

Dose-Response, 2022, v. 20, n. 2, p. 1, doi. 10.1177/15593258221105370

By:

Dong, Jie;
Huang, Xuan;
Ma, Li-Ping;
Qi, Fei;
Wang, Si-Nian;
Zhang, Zi-Qin;
Wei, Shi-Nan;
Gao, Ling;
Liu, Fang

Publication type:

Article

Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis.

Published in:

Medicina (1010660X), 2024, v. 60, n. 3, p. 360, doi. 10.3390/medicina60030360

By:

Martinez-Molina, Cristina;
Diaz-Torne, Cesar;
Park, Hye S.;
Feliu, Anna;
Vidal, Silvia;
Corominas, Hèctor

Publication type:

Article

Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study.

Published in:

Medicina (1010660X), 2022, v. 58, n. 4, p. N.PAG, doi. 10.3390/medicina58040513

By:

Kojima, Yuichi;
Nakakubo, Sho;
Takei, Nozomu;
Kamada, Keisuke;
Yamashita, Yu;
Nakamura, Junichi;
Matsumoto, Munehiro;
Horii, Hiroshi;
Sato, Kazuki;
Shima, Hideki;
Suzuki, Masaru;
Konno, Satoshi

Publication type:

Article

Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream.

Published in:

Dermatology Online Journal, 2024, v. 30, n. 3, p. 1, doi. 10.5070/D330363864

By:

Min, Mildred;
Dulai, Ajay S.;
Sivamani, Raja K.

Publication type:

Article

Use of baricitinib in treatment of COVID‐19: a systematic review.

Published in:

Medicinal Research Reviews, 2023, v. 43, n. 5, p. 1322, doi. 10.1002/med.21951

By:

Sampath, Ananyan;
Banerjee, Aditya;
Atal, Shubham;
Jhaj, Ratinder

Publication type:

Article

Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management.

Published in:

Molecules, 2023, v. 28, n. 5, p. 2237, doi. 10.3390/molecules28052237

By:

Kazi, Mohsin;
Alanazi, Yousef;
Kumar, Ashok;
Shahba, Ahmad Abdul-Wahhab;
Rizwan Ahamad, Syed;
Alghamdi, Khalid M.

Publication type:

Article

Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.

Published in:

Molecules, 2023, v. 28, n. 5, p. 2195, doi. 10.3390/molecules28052195

By:

Gu, Songtao;
Liang, Jingjing;
Zhang, Jianwei;
Liu, Zhichao;
Miao, Yang;
Wei, Yuli;
Li, Shimeng;
Gu, Jinying;
Cui, Yunyao;
Xiao, Ting;
Li, Xiaohe;
Yang, Cheng

Publication type:

Article

Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.

Published in:

Molecules, 2022, v. 27, n. 1, p. 168, doi. 10.3390/molecules27010168

By:

Anwer, Md. Khalid;
Ali, Essam A.;
Iqbal, Muzaffar;
Ahmed, Mohammed Muqtader;
Aldawsari, Mohammed F.;
Saqr, Ahmed Al;
Ansari, Mohd Nazam;
Aboudzadeh, M. Ali

Publication type:

Article

Solubility Data and Computational Modeling of Baricitinib in Various (DMSO + Water) Mixtures.

Published in:

Molecules, 2020, v. 25, n. 9, p. 2124, doi. 10.3390/molecules25092124

By:

M. Alshahrani, Saad;
Shakeel, Faiyaz;
Yaghmur, Anan

Publication type:

Article

A Hydrophilic Interaction Liquid Chromatography–Tandem Mass Spectrometry Quantitative Method for Determination of Baricitinib in Plasma, and Its Application in a Pharmacokinetic Study in Rats.

Published in:

Molecules, 2020, v. 25, n. 7, p. 1600, doi. 10.3390/molecules25071600

By:

Ezzeldin, Essam;
Iqbal, Muzaffar;
Asiri, Yousif A.;
Ali, Azza A;
Alam, Prawez;
El-Nahhas, Toqa;
Zacharis, Constantinos K.;
Markopoulou, Aikaterini

Publication type:

Article

Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat.

Published in:

Medical Principles & Practice, 2025, v. 34, n. 1, p. 75, doi. 10.1159/000541488

By:

Ekin, Ali;
Misirci, Salim;
Görünen, Ahmet;
Coskun, Belkis Nihan;
Yagiz, Burcu;
Dalkilic, Ediz;
Pehlivan, Yavuz

Publication type:

Article

Baricitinib combined with methylprednisolone on inflammatory factors in patients with severe pneumonia.

Published in:

Advances in Continuous & Discrete Models, 2025, v. 2025, n. 1, p. 1, doi. 10.1186/s13662-025-03904-0

By:

Shen, Mingfu

Publication type:

Article

RECOVERY Trial Data on Baricitinib in Patients Hospitalized with Coronavirus Disease 2019.

Published in:

touchREVIEWS in Infectious Diseases, 2022, v. 1, n. 1, p. 10, doi. 10.17925/ID.2022.1.1.10

By:

Ustianowski, Andrew

Publication type:

Article

Baricitinib statistically significantly reduced COVID-19-related mortality: a systematic review and meta-analysis of five phase III randomized, blinded and placebo-controlled clinical trials.

Published in:

Biology Methods & Protocols, 2024, v. 9, n. 1, p. 1, doi. 10.1093/biomethods/bpae002

By:

Manoharan, Sivananthan;
Ying, Lee Ying

Publication type:

Article

The JAK1/2 Inhibitor Baricitinib Mitigates the Spike-Induced Inflammatory Response of Immune and Endothelial Cells In Vitro.

Published in:

Biomedicines, 2022, v. 10, n. 9, p. 2324, doi. 10.3390/biomedicines10092324

By:

Barilli, Amelia;
Visigalli, Rossana;
Ferrari, Francesca;
Recchia Luciani, Giulia;
Soli, Maurizio;
Dall'Asta, Valeria;
Rotoli, Bianca Maria

Publication type:

Article

Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 6, p. 799, doi. 10.1007/s10096-023-04599-5

By:

Foo, Hong;
Phan, Fiona;
Bagatella, Melissa;
Petrovski, Irene;
Nagendra, Vana;
Acharya, Priya;
Levy, Miriam;
Prakoso, Emilia

Publication type:

Article

Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy.

Published in:

2025

By:

Silverberg, Jonathan I.;
Bieber, Thomas;
Paller, Amy S.;
Beck, Lisa;
Kamata, Masahiro;
Puig, Luis;
Wiseman, Marni;
Ezzedine, Khaled;
Irvine, Alan D.;
Foley, Peter;
Del Rosso, James;
Gold, Linda Stein;
Johansson, Erin;
Dossenbach, Martin;
Gallo, Gaia;
Akmaz, Buelent;
Casillas, Marta;
Karlsson, Andrei;
Curteis, Tristan;
Chovatiya, Raj

Publication type:

Literature Review

Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib.

Published in:

2024

By:

Craiglow, Brittany;
Lee, Yang Won;
Vañó-Galván, Sergio;
Egeberg, Alexander;
Dutronc, Yves;
Durand, Frederick;
Pierce, Evangeline;
Yu, Guanglei;
Chen, Yun-Fei;
Mostaghimi, Arash

Publication type:

Correction Notice